Octreotide for injectable suspension; Good manufacturing… recall
Octreotide for injectable suspension; Good manufacturing practices concerns
- Published
- 13 Jan 2026
- Agency
- Health Canada
- Country
- Canada
The hazard
Product quality
Classification: Type I
What to do
If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy. Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects. Return affected product(s) to the pharmacy where it was purchased for proper disposal. Consult a health care professional if you have used the affected product and have health concerns. Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at druginfo@tevacanada.com, if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Source: Health Canada, published 13 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.